LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Chinese Government Tips Scales for Homegrown Orthopedics
Large Joints and Extremities

Chinese Government Tips Scales for Homegrown Orthopedics

August 29, 2014 1 min read Premium comments

Advertisement

Chinese Government Tips Scales for Homegrown Orthopedics
Source: Wikimedia Commons and Jo Shigeru
Secondary

Medical device companies hoping to do business in China will meet increased competition from homegrown products, according to Emily Wasserman, writing for the online journal Fierce Medical Devices. The Chinese Health Ministry, condemning “unreasonable increases” in the cost of foreign-made products, is urging local hospitals to use Chinese-made devices. Global device makers are now reported to dominate three-quarters of China’s $34.51 billion medical device market.

Reuters News Service quoted Li Bin, the head of China’s National Health and Family Planning commission, as saying, “We want to strongly advocate health ministry organizations to use domestically-made medical devices, especially pushing top level class III hospitals to use domestically-made products.”

According to Wasserman, China’s medical device sector “is set to double to more than $50 billion by 2020 and McKinsey and Company “expects annual growth rates of around 20% for the next few years.“

One company, Shanghai’s Kinetic Medical, claims to have a 50% share in China just two years after filling its IPO. Another Chinese company, Mindray, saw a 3.4% gain in sales over last year. Wasserman quotes Mindray’s chief investment officer May Li saying that, “Private hospitals will account for 20% of all national healthcare services in China by 2015 compared to the current level of just 9%.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy